<p>A method of treating a tumor in a human patient is disclosed. The method comprises co-administering to the patient: (a) a dose of 1.5 mg tivozanib per day; and (b) a dose of 25 mg temsirolimus per week. In some embodiments of the invention, the tivozanib is administered on a repeating schedule of one dose per day for three weeks, followed by one week without tivozanib administration. The disclosed method is particularly suitable for treatment of renal cell carcinoma.</p>
申请公布号
MX2012005497(A)
申请公布日期
2012.07.03
申请号
MX20120005497
申请日期
2010.11.11
申请人
AVEO PHARMACEUTICALS, INC.
发明人
BHARGAVA, PANKAJ;ESTEVES, W., BROOKE;RYAN, JOHN, L.